Hemoglobin thresholds for transfusion in pediatric patients at a large academic health center

Sybil A Klaus1, Steven M Frank2, Jose H Salazar3

  • 1Department of Pediatrics, the Johns Hopkins Medical Institutions, Baltimore, Maryland.

Transfusion
|September 30, 2015
PubMed

Insights

Pediatric red blood cell (RBC) transfusions often exceed recommended hemoglobin (Hb) triggers. Implementing restrictive transfusion strategies in children could reduce RBC use and associated risks.

Area of Science:

  • Pediatric Hematology
  • Transfusion Medicine
  • Hospital Quality Improvement

Background:

  • Existing evidence supports hemoglobin (Hb) transfusion triggers of 7–8 g/dL for adults.
  • Limited research exists on transfusion practices in pediatric populations.

Purpose of the Study:

  • To investigate red blood cell (RBC) transfusion practices and hemoglobin (Hb) triggers in hospitalized children.
  • To compare current pediatric transfusion practices against evidence-based restrictive thresholds.

Main Methods:

  • A historical cohort study was conducted at a single academic institution.
  • Blood utilization data from 3,370 transfused pediatric patients were analyzed over four years.
  • Hemoglobin (Hb) triggers and posttransfusion Hb levels were determined and compared to a 7 g/dL restrictive threshold.

Main Results:

  • Mean Hb triggers exceeded the 7 g/dL threshold in eight of 12 pediatric services.
  • Significant variations in mean Hb triggers (>2.5 g/dL) and posttransfusion Hb levels (>3 g/dL) were observed across services (p<0.0001).
  • Between 25% and 90% of transfused pediatric patients had Hb triggers above the restrictive range, depending on the service.

Conclusions:

  • Red blood cell (RBC) transfusion practices vary significantly among hospitalized children.
  • Mean Hb triggers are frequently above restrictive thresholds, suggesting potential overuse of RBC transfusions.
  • Adopting a restrictive transfusion strategy could decrease RBC utilization, mitigating associated risks and costs.
Abstract

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.7K
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
8.3K
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
3.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
467
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
333
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
375